A Chronopharmacodynamic Study on Standard Heparin, a Low Molecular Weight Heparin (Nadroparin) and Danaproid: Establishing and Comparing the Daily Variations of These Drugs in Rats

Publisher： Karger

E-ISSN： 1424-8840|30|5|233-242

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.30, Iss.5, 2001-03, pp. : 233-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thromboprophylaxis with Low-Molecular- Weight Heparin: Economic Considerations

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 141-145

Karger

Access to resources Recommend Favorite

Effect of Low-Molecular-Weight Heparin on Potassium Homeostasis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2002-10 ,pp. : 107-110

Karger

Access to resources Recommend Favorite

Antithrombotic drugs in acutely ill medical patients: review and meta-analysis of interventional trials with low-molecular-weight heparin and fondaparinux

By Loffredo Lorenzo   Perri Ludovica   Catasca Elisa   Del Ben Maria   Angelico Francesco   Violi Francesco  

Clinical Practice, Vol. 10, Iss. 5, 2013-09 ,pp. : 615-627

Future Medicine

Access to resources Recommend Favorite

Dalteparin, a Low-Molecular-Weight Heparin, Reduces Ischaemia/Reperfusion-Induced Liver Injury in Rats by Increasing the Hepatic Level of Prostacyclin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 170-171

Karger

Access to resources Recommend Favorite

Combinations of Low Doses of Unfractionated Heparin and of Low-Molecular-Weight Heparin Prevent Experimental Venous Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 6, 2006-06 ,pp. : 263-268

Karger

Access to resources Recommend Favorite